Skip to Content

Tag: Kerecis


In brief: ADS taps Bill Mixon as CEO, Coloplast buys Kerecis

July 12, 2023HME News Staff

CARLSBAD, Calif. - Advanced Diabetes Supply has appointed Bill Mixon, who previously led National Seating & Mobility, as its CEO.  The announcement follows the transition of the company’s co-founders and co-CEOs, Mark Howard and Tim Cady, to strategic advisory roles as members of the board of directors.  “Bill has provided valuable insight and support to the ADS leadership team as a board member for the last two years,” said Jeffrey Abramoff, a partner at Court Square,...

Advanced Diabetes Supply, Bill Mixon, Coloplast, Kerecis

Read Full Articlered right arrow icon


Coloplast expands into biologics wound care segment 

July 10, 2023HME News Staff

MINNEAPOLIS – Coloplast has signed an agreement to buy Kerecis, a biotech company based in Iceland that is pioneering the use of fish skin in the regenerative medicine market, for up to $1.3 billion.  Coloplast will pay $1.2 billion upfront on a cash and debt-free basis and will pay up to a $100 million earnout dependent on financial performance in fiscal year 2023-24.  “The advanced wound care market holds significant untapped potential, and today Coloplast is only present...

Coloplast, Kerecis, Mergers & Acquisitions (M&A)

Read Full Articlered right arrow icon